A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2014
At a glance
- Drugs Gefitinib (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 22 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2013 Planned End Date changed from 1 Sep 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 08 Apr 2013 New trial record